Quarterly review of the BEL 20®, BEL MID® and BEL SMALL®

Brussels, 12 September 2018 - Euronext today announced the results of the quarterly review for the BEL 20®, BEL Mid®, and BEL Small®. The changes due to the review will be effective from 24 September 2018.

Results of the June 2018 Review:

BEL 20®

No changes

BEL Mid®

Inclusion of:

Exclusion of:



BEL Small®

Inclusion of:

Exclusion of:



Home Invest BE


The compiler retains the right to change the published selection, for instance in case of a removal due to a take-over, till the publication of the final data after close of Wednesday 19 September 2018. All events happening after that date will not lead to a replacement of the selected company that possibly needs to be removed from the final selection.

Review BEL 20®, BEL Mid®, and BEL Small®

The BEL 20®, BEL Mid®, and BEL Small® is reviewed quarterly (March, June, September, December). The full annual review is in March. The June, September and December reviews serve to include new entrants in case the index consists of less than the standard number of constituents and to facilitate inclusion of highly ranked non-constituents, for example recently listed companies.


[1] Formerly known as ThromboGenics